Maternal folate, vitamin B12 and homocysteine levels in pregnancies affected by congenital malformations other than neural tube defects

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 91, Issue 7, 2011, Pages 610-615

  Sutton, Marie ^a   Mills, James L ^b   Molloy, Anne M ^c   Troendle, James F ^b,d   Brody, Lawrence C ^e   Conley, Mary ^b   Mc Donnell, Robert ^f   Scott, John M ^g   Kirke, Peadar N ^a  

^a HEALTH RESEARCH BOARD   (Ireland)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c TRINITY COLLEGE DUBLIN   (Ireland)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^f DR STEEVENS HOSPITAL   (Ireland)

^g TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BIRTH DEFECT; CASE CONTROL STUDY; CLEFT LIP PALATE; CLEFT PALATE; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CONTROLLED STUDY; DIGESTIVE SYSTEM MALFORMATION; DOWN SYNDROME; FEMALE; FOLIC ACID BLOOD LEVEL; FOOT MALFORMATION; HUMAN; HUMAN TISSUE; HYPOSPADIAS; INBORN ERROR OF METABOLISM; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MUSCULOSKELETAL DISEASE; MUSCULOSKELETAL SYSTEM MALFORMATION; NEURAL TUBE DEFECT; POLYDACTYLY; PREGNANCY; PRENATAL PERIOD; PRIORITY JOURNAL; PYLORUS STENOSIS; SYNDACTYLY; URINARY TRACT MALFORMATION; VITAMIN BLOOD LEVEL;

CONGENITAL ABNORMALITIES; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; NEURAL TUBE DEFECTS; PREGNANCY; RISK FACTORS; VITAMIN B 12;

EID: 79960044970     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20817     Document Type: Article

References (35)

1. Botto LD, Mulinare J, Erickson JD, et al. 2000. Occurrence of congenital heart defects in relation to maternal mulitivitamin use. Am J Epidemiol 151(9): 878-884.
2. Botto LD, Olney RS, Erickson JD, et al. 2004. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet C Semin Med Genet 125(1): 12-21.
3. Bower C, Miller M, Payne J, et al. 2006. Folate intake and the primary prevention of non-neural birth defects. Aust N Z J Public Health 30(3): 258-261.
4. Canfield MA, Collins JS, Botto LD, et al. 2005. Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study. Birth Defects Res A Clin Mol Teratol 73(10): 679-689.
5. Castilla E, Orioli I, Lopez-Camelo J, et al. 2003. Preliminary data on changes in neural tube defect prevalence rates after folic acid fortification in South America. Am J Med Genet A 123A(2): 123-128.
6. Czeizel A. 1981. Schisis-association. Am J Med Genet 10(1): 25-35.
7. Czeizel AE. 1998. Periconceptional folic acid containing multivitamin supplementation. Eur J Obstet Gynecol Reprod Biol 78(2): 151-161.
8. Czeizel AE, Toth M, Rockenbauer M, et al. 1996. Population-based case control study of folic acid supplementation during pregnancy. Teratology 53(6): 345-351.
9. EUROCAT. Available at:. Accessed on.
10. EUROCAT Working Group, editor. 1991. Surveillance of congenital anomalies 1980-1988. EUROCAT Report 4. Brussels: Department of Epidemiology, Catholic University of Louvain.
11. Hayes C, Werler MM, Willett WC, et al. 1996. Case-control study of periconceptional folic acid supplementation and oral clefts. Am J Epidemiol 143(12): 1229-1234.
12. Ionescu-Ittu R, Marelli AJ, Mackie AS, et al. 2009. Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec. Canada BMJ 338: b1673.
13. Itikala PR, Watkins ML, Mulinare J, et al. 2001. Maternal multivitamin use and orofacial clefts in offspring. Teratology 63(2): 79-86.
14. Johnson CY, Little J. 2008. Folate intake, markers of folate status and oral clefts: is the evidence converging? Int J Epidemiol 37(5): 1041-1058.
15. Kelleher BP, O'Broin SD. 1991. Microbiological assay for vitamin B12 performed in 96-well microtitre plates. J Clin Pathol 44: 592-595.
16. Khoury MJ, Cordero JF, Mulinare J, et al. 1989. Selected midline defect associations: a population study. Pediatrics 84(2): 266-272.
17. Kirke PN, Molloy AM, Daly LE, et al. 1993. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 86(11): 703-708.
18. Li DK, Daling JR, Mueller BA, et al. 1995. Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies. Epidemiology 6(3): 212-218.
19. Mills JL, McPartlin JM, Kirke PN, et al. 1995. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345(8943): 149-151.
20. Molloy AM, Kirke PN, Troendle JF, et al. 2009. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic acid fortification. Pediatrics 123(3): 917-923.
21. Molloy AM, Scott JM. 1997. Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol 281: 43-53.
22. O'Leary VB, Parle-McDermott A, Molloy AM, et al. 2002. MTRR and MTHFR polymorphism: link to Down syndrome? Am J Med Genet 107(2): 151-155.
23. Opitz JM. 1982. The developmental field concept in clinical genetics. J Pediatr 101(5): 805-809.
24. Opitz JM. 1994. Associations and syndromes: terminology in clinical genetics and birth defects epidemiology: comments on Khoury, Moore, and Evans Am J Med Genet 49(1): 14-20.
25. Ray JG, Meier C, Vermeulen MJ, et al. 2003. Association between folic acid food fortification and congenital orofacial clefts. J Pediatr 143(6): 805-807.
26. Shaw GM, Croen LA, Todoroff K, et al. 2000. Periconceptional intake of vitamin supplements and risk of multiple congenital anomalies. Am J Med Genet 93(3): 188-193.
27. Shaw GM, Lammer EJ, Wasserman CR, et al. 1995a. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 346: 393-396.
28. Shaw GM, O'Malley CD, Wasserman CR, et al. 1995b. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet 59(4): 536-545.
29. Steegers-Theunissen RP, Boers GH, Blom HJ, et al. 1995. Neural tube defects and elevated homocysteine levels in amniotic fluid. Am J Obstet Gynecol 172(5): 1436-1441.
30. Tolarova M, Harris J. 1995. Reduced recurrence of orofacial clefts after periconceptional supplementation with high-dose folic acid and multivitamins. Teratology 51: 71-78.
31. Ubbink JB, Hayward Vermaak WJ, Bissbort S, et al. 1991. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 565(1-2): 441-446.
32. Ueland PM, Refsum H, Stabler SP, et al. 1993. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 39: 1764-1779.
33. van der Put NM, van Straaten HW, Trijbels FJ, et al. 2001. Folate, homocysteine and neural tube defects: an overview. Exp Biol Med (Maywood) 226(4): 243-270.
34. Werler MM, Hayes C, Louik C, et al. 1999. Multivitamin supplementation and risk of birth defects. Am J Epidemiol 150(7): 675-682.
35. Yang Q, Khoury MJ, Olney RS, et al. 1997. Does periconceptional multivitamin use reduce the risk for limb deficiency in offspring? Epidemiology 8(2): 157-161.